apl. Prof. Dr. Piotr Lewczuk

Medizinische Fakultät Department of Psychiatry and Psychotherapy

The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review (2018) Hansson O, Mikulskis A, Fagan AM, Teunissen C, Zetterberg H, Vanderstichele H, Molinuevo JL, et al. Journal article Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer's disease (2018) Lewczuk P, Ermann N, Andreasson U, Schultheis C, Podhorna J, Spitzer P, Maler JM, et al. Journal article Interlaboratory proficiency processing scheme in CSF aliquoting: implementation and assessment based on biomarkers of Alzheimer's disease (2018) Lewczuk P, Gaignaux A, Kofanova O, Ermann N, Betsou F, Brandner S, Mroczko B, et al. Journal article CSF nonphosphorylated Tau as a biomarker for the discrimination of AD from CJD (2018) Ermann N, Lewczuk P, Schmitz M, Lange P, Knipper T, Goebel S, Kornhuber J, et al. Journal article Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry (2018) Lewczuk P, Riederer P, O'Bryant SE, Verbeek MM, Dubois B, Visser PJ, Jellinger KA, et al. Journal article A Specific Reduction in Aβ1-42 vs. a Universal Loss of Aβ Peptides in CSF Differentiates Alzheimer's Disease From Meningitis and Multiple Sclerosis (2018) Spitzer P, Lang R, Oberstein T, Lewczuk P, Ermann N, Huttner H, Masouris I, et al. Journal article Cerebrospinal Fluid Biomarkers and Clinical Progression in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment (2017) Wolfsgruber S, Polcher A, Koppara A, Kleineidam L, Froelich L, Peters O, Huell M, et al. Journal article CSF Aβ1-42- an excellent but complicated Alzheimer's biomarker - a route to standardisation (2017) Kuhlmann J, Andreasson U, Pannee J, Bjerke M, Portelius E, Leinenbach A, Bittner T, et al. Journal article Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer's Disease (2017) Lewczuk P, Matzen A, Blennow K, Parnetti L, Molinuevo JL, Eusebi P, Kornhuber J, et al. Journal article Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic (2017) O'Bryant SE, Mielke MM, Rissman RA, Lista S, Vanderstichele H, Zetterberg H, Lewczuk P, et al. Journal article